Literature DB >> 20199731

[Protective effects of curcumin on neonatal rats with necrotizing enterocolitis].

Sheng-Hua Jia1, Hong Wei, Jia-Lin Yu, Xiao-Di Wei, Xiao-Ping Zhang, Jin-Chun Li.   

Abstract

OBJECTIVE: This study examined the effects of curcumin on intestinal histopathological changes, cyclooxygenase-2 (COX-2) expression, and tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) concentrations in neonatal rats with necrotizing enterocolitis (NEC), in order to investigate the effects of curcumin against NEC.
METHODS: Forty neonatal rats were randomly divided into four groups (n=10 each): normal control, solvent control, NEC model, and curcumin intervention. The general situations of rats were observed for 3 consecutive days, and the rats were then sacrificed on the 4th day. Intestinal tissues were obtained for examining the histopathological changes, COX-2 expression, and TNF-alpha and IL-10 concentrations.
RESULTS: Curcumin treatment ameliorated the general situations and histopathological signs in rats with NEC. TNF-alpha and IL-10 concentrations in the NEC model and the curcumin intervention groups increased significantly compared with those in the normal and solvent control groups (p<0.05). The concentration of TNF-alpha decreased (p<0.05), while the concentration of IL-10 increased significantly in the curcumin intervention group in comparison with the NEC model group (p<0.05). Immunohistochemistry results indicated that the positive expression of COX-2 in the curcumin intervention group was significantly lower than that in the NEC model group.
CONCLUSIONS: Curcumin has protective effects against NEC in neonatal rats, possibly through inhibiting COX-2 expression, reducing TNF-alpha content, and increasing IL-10 content.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199731

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  7 in total

Review 1.  Discovery of curcumin, a component of golden spice, and its miraculous biological activities.

Authors:  Subash C Gupta; Sridevi Patchva; Wonil Koh; Bharat B Aggarwal
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-03       Impact factor: 2.557

Review 2.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

3.  Non-intervention observation: Dynamic evolution laws of inflammatory response in necrotizing enterocolitis.

Authors:  Wei Wang; Li Xue; Tongsheng Ma; Yuan Li; Zhenguang Li
Journal:  Exp Ther Med       Date:  2016-07-25       Impact factor: 2.447

4.  FLLL32, a curcumin analog, ameliorates intestinal injury in necrotizing enterocolitis.

Authors:  Jeffrey Eckert; Brian Scott; Shelley M Lawrence; Michael Ihnat; Hala Chaaban
Journal:  J Inflamm Res       Date:  2017-06-14

5.  Curcumin Alleviates IUGR Jejunum Damage by Increasing Antioxidant Capacity through Nrf2/Keap1 Pathway in Growing Pigs.

Authors:  Enfa Yan; Jiaqi Zhang; Hongli Han; Jiamin Wu; Zhending Gan; Chengheng Wei; Lili Zhang; Chao Wang; Tian Wang
Journal:  Animals (Basel)       Date:  2019-12-24       Impact factor: 2.752

6.  Different Processed Products of Curcumae Radix Regulate Pain-Related Substances in a Rat Model of Qi Stagnation and Blood Stasis.

Authors:  Zhimin Chen; Lin Hu; Yujiao Liao; Xi Zhang; Zhuo Yang; Changjiang Hu; Lingying Yu
Journal:  Front Pharmacol       Date:  2020-03-20       Impact factor: 5.810

7.  Curcumin improves necrotising microscopic colitis and cell pyroptosis by activating SIRT1/NRF2 and inhibiting the TLR4 signalling pathway in newborn rats.

Authors:  Yiyu Yin; Xiaole Wu; Bei Peng; Huaxin Zou; Shixian Li; Jian Wang; Junhua Cao
Journal:  Innate Immun       Date:  2020-09-13       Impact factor: 2.680

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.